Effect of age on the efficacy and safety of Panax notoginseng saponins in acute ischemic stroke: a prespecified secondary analysis of the PANDA study
This prespecified secondary analysis suggests that AIS patients can potentially benefit from Xuesaitong treatment in achieving functional independence, irrespective of age. Furthermore, older individuals may experience more substantial clinical benefits from Xuesaitong soft capsules for AIS.
Authors
- Luda Feng (ORCID: https://orcid.org/0000-0002-7259-4421)
- Xunming Ji (ORCID: https://orcid.org/0000-0003-0293-2744)
- Chi Zhang (ORCID: https://orcid.org/0000-0001-5427-2966)
- Haiqing Song (ORCID: https://orcid.org/0000-0003-0390-0920)
- Xiaoli Zhang (ORCID: https://orcid.org/0000-0001-7393-0987)
- Tingting Li (ORCID: https://orcid.org/0000-0002-6319-9518)
- Anxin Wang (ORCID: https://orcid.org/0000-0003-4351-2877)
- Ying Gao (ORCID: https://orcid.org/0000-0002-5409-7675)
- Peipei Du (ORCID: https://orcid.org/0000-0001-6582-8384)
Institutions
- Beijing University of Chinese Medicine (CN)
- Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Beijing Tian Tan Hospital (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Chinese Medicine
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1186/s13020-025-01101-5
- Citations
- 2
- Primary Topic
- Ginseng Biological Effects and Applications
- Type
- article
- Field-Weighted Citation Impact
- 1.61